ELISE BJELICA: Open Payments
NPI 1700328515 · LAKELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,502 in 72 payments from 14 companies in 2025. Trend: 2023 $2,188 · 2024 $1,265 · 2025 $1,502
Food & beverage: $1,484Education: $18
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $296 |
| Novartis Pharmaceuticals Corporation | 12 | $235 |
| Janssen Biotech, Inc. | 10 | $225 |
| GENZYME CORPORATION | 5 | $141 |
| Galderma Laboratories, L.P. | 8 | $138 |
| Regeneron Healthcare Solutions, Inc. | 3 | $76 |
| LEO Pharma Inc. | 3 | $75 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $68 |
| PFIZER INC. | 3 | $63 |
| Almirall LLC | 2 | $48 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, COSENTYX, RINVOQ, NEMLUVIO, LIBTAYO, ADBRY.
Industry payments across FL — which companies pay providers there.
